Health & Biotech
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Clinuvel Pharmaceuticals.
RELATED STOCKHEAD STORIES
News
ASX Large Caps: Shareholders caught with pants down in brutal selloff on Wednesday
News
Short & Caught: Popular lithium plays among most shorted ASX stocks
Experts
ScoPo’s Powerplays: ASX health stocks finish reporting season in pretty strong shape
News
Trading Places: BGH ups Virtus stake to above 50pc as battle for fertility company escalates
News
Short & Caught: Flight Centre hits turbulence as ASX’s most shorted stock
News
ASX Small Cap Lunch Wrap: Who’s deconstructing their tendies today?
Health & Biotech
ASX Health Stocks: Clinuvel reveals study results, and Cann’s Mildura cannabis facility is a go
Health & Biotech
ScoPo’s Powerplays: Case of courage under fire for ASX health stocks
Experts
ScoPo’s Powerplays: Who’s staying afloat in the inflation storm?
Health & Biotech
ASX Health Stocks: Clinical trials gather pace for Visioneering Tech, Anteris and other biotechs
Health & Biotech
Mesoblast and the ASX’s other big biotechs have intrigued investors this year; here’s what’s in store next
Health & Biotech
ScoPo’s Powerplays: AGM season ‘flushes out negative surprises’ but creates buying opportunities
News
Here are the top ASX large cap movers for Friday
Health & Biotech
ScoPo’s Powerplays: Profit-taking on the cards for health stocks that have had good runs
Health & Biotech
ASX Health Stocks: Acrux flags testosterone solution with an armpit application, Clinuvel posts record revenues
Director Trades
Directors Trades: It’s a new financial year, so who’s hoping for better returns and who’s selling to pay a tax bill?
Health & Biotech
